REPORTS

Let’s Pullulate and Expand Your Business

Epigenetics Market - Global Professional Analysis and Forecast to 2026

Oct 13, 2019  |  216 PAGES  |  REPORT CODE: CMM208059
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Epigenetics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 12.4% during the forecast period.

This report presents the market size and development trends by detailing the Epigenetics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Epigenetics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Epigenetics industry and will help you to build a panoramic view of the industrial development.

Epigenetics Market, By Type:

  • Reagents

  • Kits

  • Instruments

  • Enzymes

  • Services

Epigenetics Market, By Application:

  • Oncology

  • Non-Oncology

  • Solid Tumors

  • Liquid Tumors

  • Inflammatory Diseases

  • Metabolic Diseases

  • Infectious Diseases

  • Cardiovascular Diseases

Some of the leading players are as follows:

  • Thermo Fisher Scientific

  • Zymo Research Corporation

  • Qiagen

  • Illumina Inc

  • Active Motif Inc.

  • Cellcentric Limited

  • Abcam

  • Diagenode

  • Eisai Co. Ltd.

  • Roche

  • Syndex Pharmaceuticals

  • Oncoloys Biopharma Inc.

  • Chroma Therapeutics

  • Novartis AG

  • Merck & Co. Ltd.

  • Valirx Plc

  • Sigma-Aldrich Corporation

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Epigenetics Market: Technology Type Analysis

  • 4.1 Epigenetics Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Epigenetics Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Reagents

    • 4.3.2 Kits

    • 4.3.3 Instruments

    • 4.3.4 Enzymes

    • 4.3.5 Services

5 Epigenetics Market: Product Analysis

  • 5.1 Epigenetics Product Market Share Analysis, 2018 & 2026

  • 5.2 Epigenetics Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Epigenetics Market: Application Analysis

  • 6.1 Epigenetics Application Market Share Analysis, 2018 & 2026

  • 6.2 Epigenetics Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Oncology

    • 6.3.2 Non-Oncology

    • 6.3.3 Solid Tumors

    • 6.3.4 Liquid Tumors

    • 6.3.5 Inflammatory Diseases

    • 6.3.6 Metabolic Diseases

    • 6.3.7 Infectious Diseases

    • 6.3.8 Cardiovascular Diseases

7 Epigenetics Market: Regional Analysis

  • 7.1 Epigenetics Regional Market Share Analysis, 2018 & 2026

  • 7.2 Epigenetics Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Thermo Fisher Scientific

    • 9.1.1 Thermo Fisher Scientific Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Zymo Research Corporation

    • 9.2.1 Zymo Research Corporation Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Qiagen

    • 9.3.1 Qiagen Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Illumina Inc

    • 9.4.1 Illumina Inc Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Active Motif Inc.

    • 9.5.1 Active Motif Inc. Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Cellcentric Limited

    • 9.6.1 Cellcentric Limited Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Abcam

    • 9.7.1 Abcam Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Diagenode

    • 9.8.1 Diagenode Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Eisai Co. Ltd.

    • 9.9.1 Eisai Co. Ltd. Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Roche

    • 9.10.1 Roche Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Syndex Pharmaceuticals

    • 9.11.1 Syndex Pharmaceuticals Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Oncoloys Biopharma Inc.

    • 9.12.1 Oncoloys Biopharma Inc. Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Chroma Therapeutics

    • 9.13.1 Chroma Therapeutics Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Novartis AG

    • 9.14.1 Novartis AG Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Merck & Co. Ltd.

    • 9.15.1 Merck & Co. Ltd. Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Valirx Plc

    • 9.16.1 Valirx Plc Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Sigma-Aldrich Corporation

    • 9.17.1 Sigma-Aldrich Corporation Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

 

The List of Tables and Figures (Totals 80 Figures and 128 Tables)

  • Figure Reagents Epigenetics market, 2015 - 2026 (USD Million)

  • Figure Kits Epigenetics market, 2015 - 2026 (USD Million)

  • Figure Instruments Epigenetics market, 2015 - 2026 (USD Million)

  • Figure Enzymes Epigenetics market, 2015 - 2026 (USD Million)

  • Figure Services Epigenetics market, 2015 - 2026 (USD Million)

  • Figure Oncology market, 2015 - 2026 (USD Million)

  • Figure Non-Oncology market, 2015 - 2026 (USD Million)

  • Figure Solid Tumors market, 2015 - 2026 (USD Million)

  • Figure Liquid Tumors market, 2015 - 2026 (USD Million)

  • Figure Inflammatory Diseases market, 2015 - 2026 (USD Million)

  • Figure Metabolic Diseases market, 2015 - 2026 (USD Million)

  • Figure Infectious Diseases market, 2015 - 2026 (USD Million)

  • Figure Cardiovascular Diseases market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Epigenetics market, by country, 2015 - 2026 (USD Million)

  • Table North America Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table North America Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table North America Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Canada Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Canada Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Europe Epigenetics market, by country, 2015 - 2026 (USD Million)

  • Table Europe Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Europe Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Europe Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Germany Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Germany Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table France Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table France Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Italy Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Italy Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Spain Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Spain Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Epigenetics market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table China Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table China Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Japan Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Japan Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table India Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table India Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Epigenetics market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table MEA Epigenetics market, by country, 2015 - 2026 (USD Million)

  • Table MEA Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table MEA Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table MEA Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Epigenetics market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Epigenetics market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Epigenetics market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zymo Research Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Qiagen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Illumina Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Active Motif Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cellcentric Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abcam Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Diagenode Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eisai Co. Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Syndex Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Oncoloys Biopharma Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Chroma Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck & Co. Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Valirx Plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sigma-Aldrich Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top